scholarly article | Q13442814 |
P2093 | author name string | Doo-Sup Choi | |
Moonnoh R Lee | |||
Youssef Sari | |||
Sai N Sreemantula | |||
P2860 | cites work | Ceftriaxone restores glutamate homeostasis and prevents relapse to cocaine seeking | Q24656626 |
Glutamate uptake | Q28190140 | ||
Limbic activation during cue-induced cocaine craving | Q28369526 | ||
What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? | Q29618655 | ||
Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex | Q29619998 | ||
ENT1 regulates ethanol-sensitive EAAT2 expression and function in astrocytes | Q34035612 | ||
Ceftriaxone-induced up-regulation of cortical and striatal GLT1 in the R6/2 model of Huntington's disease | Q34053585 | ||
Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis | Q34300016 | ||
Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. | Q34382218 | ||
Regulation of ethanol-sensitive EAAT2 expression through adenosine A1 receptor in astrocytes | Q34671783 | ||
Type 1 equilibrative nucleoside transporter regulates ethanol drinking through accumbal N-methyl-D-aspartate receptor signaling | Q34958402 | ||
Ceftriaxone, a beta-lactam antibiotic, reduces ethanol consumption in alcohol-preferring rats | Q35015226 | ||
Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics. | Q35087565 | ||
N-methyl-D-aspartate glutamate receptors and alcoholism: reward, dependence, treatment, and vulnerability | Q35153745 | ||
Glutamate systems in cocaine addiction | Q35690222 | ||
Adenosine and glutamate signaling in neuron-glial interactions: implications in alcoholism and sleep disorders | Q35951700 | ||
Neuroimmunophilin GPI-1046 reduces ethanol consumption in part through activation of GLT1 in alcohol-preferring rats | Q36422300 | ||
Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouse | Q36713909 | ||
Ceftriaxone, a beta-lactam antibiotic, attenuates relapse-like ethanol-drinking behavior in alcohol-preferring rats | Q36853227 | ||
Effects of ceftriaxone on the acquisition and maintenance of ethanol drinking in peri-adolescent and adult female alcohol-preferring (P) rats | Q36855000 | ||
Upregulation of GLT1 attenuates cue-induced reinstatement of cocaine-seeking behavior in rats | Q37332208 | ||
Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis. | Q41341457 | ||
Ethanol exposure differentially alters central monoamine neurotransmission in alcohol-preferring versus -nonpreferring rats. | Q41608536 | ||
Ethanol alters glutamate but not adenosine uptake in rat astrocytes: evidence for protein kinase C involvement | Q43962329 | ||
Functional changes of glial glutamate transporter GLT-1 during ischemia: an in vivo study in the hippocampal CA1 of normal mice and mutant mice lacking GLT-1. | Q44540557 | ||
The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference. | Q44982517 | ||
Transgenic expression of human equilibrative nucleoside transporter 1 in mouse neurons | Q46119603 | ||
Ethanol exposure decreases glutamate uptake in the nucleus accumbens | Q46381488 | ||
A postsynaptic interaction between dopamine D1 and NMDA receptors promotes presynaptic inhibition in the rat nucleus accumbens via adenosine release. | Q48658263 | ||
Glutamate transport is downregulated in the cerebral cortex of alcohol-preferring rats. | Q49018776 | ||
Regional deafferentation down-regulates subtypes of glutamate transporter proteins | Q71832642 | ||
Regulation of glutamate uptake in astrocytes continuously exposed to ethanol | Q73994164 | ||
P433 | issue | 3 | |
P921 | main subject | ceftriaxone | Q421713 |
P304 | page(s) | 779-787 | |
P577 | publication date | 2013-07-27 | |
P1433 | published in | Journal of Molecular Neuroscience | Q15708870 |
P1476 | title | Ceftriaxone treatment affects the levels of GLT1 and ENT1 as well as ethanol intake in alcohol-preferring rats | |
P478 | volume | 51 |
Q28068256 | A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction |
Q89441164 | Alcohol and Cocaine Exposure Modulates ABCB1 and ABCG2 Transporters in Male Alcohol-Preferring Rats |
Q41664989 | Alcohol consumption increases basal extracellular glutamate in the nucleus accumbens core of Sprague-Dawley rats without increasing spontaneous glutamate release. |
Q36037560 | Amoxicillin and amoxicillin/clavulanate reduce ethanol intake and increase GLT-1 expression as well as AKT phosphorylation in mesocorticolimbic regions. |
Q26996339 | Astrocytic dysfunction and addiction: consequences of impaired glutamate homeostasis |
Q48027529 | Astroglia, Glutamatergic Transmission and Psychiatric Diseases |
Q30578263 | Attenuation of ethanol withdrawal by ceftriaxone-induced upregulation of glutamate transporter EAAT2. |
Q47437172 | Beyond the "First Hit": Marked Inhibition by N-Acetyl Cysteine of Chronic Ethanol Intake But Not of Early Ethanol Intake. Parallel Effects on Ethanol-Induced Saccharin Motivation. |
Q91789963 | Caffeine induces neurobehavioral effects through modulating neurotransmitters |
Q35161340 | Ceftriaxone and cefazolin attenuate the cue-primed reinstatement of alcohol-seeking |
Q35956322 | Ceftriaxone attenuates ethanol drinking and restores extracellular glutamate concentration through normalization of GLT-1 in nucleus accumbens of male alcohol-preferring rats |
Q36581692 | Clavulanic acid enhances glutamate transporter subtype I (GLT-1) expression and decreases reinforcing efficacy of cocaine in mice |
Q34021956 | Clavulanic acid reduces rewarding, hyperthermic and locomotor-sensitizing effects of morphine in rats: a new indication for an old drug? |
Q28828473 | Development and evaluation of a calcium alginate based oral ceftriaxone sodium formulation |
Q35077751 | Effectiveness of Ceftriaxone Treatment in Preventing Relapse-like Drinking Behavior Following Long-term Ethanol Dependence in P Rats |
Q35417634 | Effects of (R)-(-)-5-methyl-1-nicotinoyl-2-pyrazoline on glutamate transporter 1 and cysteine/glutamate exchanger as well as ethanol drinking behavior in male, alcohol-preferring rats. |
Q48416598 | Effects of Administered Ethanol and Methamphetamine on Glial Glutamate Transporters in Rat Striatum and Hippocampus |
Q36829679 | Effects of Amoxicillin and Augmentin on Cystine-Glutamate Exchanger and Glutamate Transporter 1 Isoforms as well as Ethanol Intake in Alcohol-Preferring Rats |
Q37273362 | Effects of Ceftriaxone on Glial Glutamate Transporters in Wistar Rats Administered Sequential Ethanol and Methamphetamine |
Q93337978 | Effects of Clavulanic Acid Treatment on Reinstatement to Methamphetamine, Glial Glutamate Transporters, and mGluR 2/3 Expression in P Rats Exposed to Ethanol |
Q34426947 | Effects of MS-153 on chronic ethanol consumption and GLT1 modulation of glutamate levels in male alcohol-preferring rats. |
Q35533496 | Effects of ampicillin, cefazolin and cefoperazone treatments on GLT-1 expressions in the mesocorticolimbic system and ethanol intake in alcohol-preferring rats. |
Q35738010 | Effects of ceftriaxone on GLT1 isoforms, xCT and associated signaling pathways in P rats exposed to ethanol |
Q34250509 | Effects of ceftriaxone on ethanol intake: a possible role for xCT and GLT-1 isoforms modulation of glutamate levels in P rats |
Q48390347 | Effects of orally administered Augmentin on glutamate transporter 1, cystine-glutamate exchanger expression and ethanol intake in alcohol-preferring rats |
Q53333507 | Effects of repeated cocaine exposure and withdrawal on voluntary ethanol drinking, and the expression of glial glutamate transporters in mesocorticolimbic system of P rats. |
Q40502974 | Equilibrative nucleoside transporter ENT1 as a biomarker of Huntington disease |
Q30367006 | Ethanol-Associated Changes in Glutamate Reward Neurocircuitry: A Minireview of Clinical and Preclinical Genetic Findings. |
Q90473578 | General Pathophysiology of Astroglia |
Q43076075 | Glial and neuroinflammatory targets for treating substance use disorders |
Q38729846 | Glutamate Transport: A New Bench to Bedside Mechanism for Treating Drug Abuse |
Q99201953 | Influence of n-acetylcysteine maintenance on the pharmacodynamic effects of oral ethanol |
Q46487290 | Intracerebral Stem Cell Administration Inhibits Relapse-like Alcohol Drinking in Rats |
Q90884465 | Pregabalin: Potential for Addiction and a Possible Glutamatergic Mechanism |
Q39142990 | Rat animal models for screening medications to treat alcohol use disorders. |
Q34999412 | Redox-based epigenetic status in drug addiction: a potential contributor to gene priming and a mechanistic rationale for metabolic intervention |
Q47789766 | Regulation of glutamate transporter 1 (GLT-1) gene expression by cocaine self-administration and withdrawal |
Q35110324 | Repeated cycles of chronic intermittent ethanol exposure increases basal glutamate in the nucleus accumbens of mice without affecting glutamate transport |
Q64118653 | Repurposing of the β-Lactam Antibiotic, Ceftriaxone for Neurological Disorders: A Review |
Q26750910 | Role of astrocytic glutamate transporter in alcohol use disorder |
Q33912290 | Role of glutamate transporter 1 in the attenuation of alcohol intake |
Q47860319 | Sex and Adolescent Ethanol Exposure Influence Pavlovian Conditioned Approach. |
Q37059772 | Signals from the Fourth Dimension Regulate Drug Relapse |
Q27002488 | Targeting glutamate uptake to treat alcohol use disorders |
Q37062547 | The Nucleus Accumbens: Mechanisms of Addiction across Drug Classes Reflect the Importance of Glutamate Homeostasis |
Q38589482 | Translational potential of astrocytes in brain disorders |
Q47920494 | β-Lactamase inhibitor, clavulanic acid, attenuates ethanol intake and increases glial glutamate transporters expression in alcohol preferring rats |
Search more.